🔰Platelets in Unani Medicine: From “Dam” to a Functional Therapeutic Concept
A common mistake is to equate a low platelet count simply with Fasad-e-Dam. Platelets are not synonymous with the classical concept of whole blood. Therapeutically, we need a more functional interpretation.
Modern physiology tells us that platelets arise from megakaryocytes in the bone marrow, circulate in blood and are regulated through production, survival, destruction and splenic sequestration.
Applied Unani can translate this into a functional axis:
Meda → Ghiza → Kabid → Dam → Marrow → Platelet recovery
with an additional:
Dam ↔ Quwwat-e-Mudabbira/Immune ↔ Tilli axis
Thus, thrombocytopenia may represent different therapeutic phenotypes—not one disease.
🔹 The Two-Murakkab Model
1️⃣ Habb-e-Tinkar + Jawarish Jalinus
Meda → Ghiza → Hematopoietic Recovery
The therapeutic hypothesis is indirect:
Islah-e-Meda
↓
better digestion and Ghiza assimilation
↓
nutritional/convalescent recovery
↓
support of hematopoiesis
↓
potential platelet recovery
Best conceptual phenotype:
Post-viral weakness + anorexia + dyspepsia + nutritional impairment.
This should therefore be described as a Meda–Ghiza supportive combination, not a proven direct platelet booster.
2️⃣ Habb-e-Papita + Sharbat Unnab
Dam → Immune Modulation → Platelet Recovery
This combination is particularly interesting in dengue-associated thrombocytopenia.
Carica papaya leaf preparations have human clinical evidence suggesting faster platelet recovery in dengue, although evidence quality remains limited and this does not establish improved major clinical outcomes.
The proposed Applied Unani model is:
Habb-e-Papita
→ potential platelet-directed + immunomodulatory effects
Sharbat Unnab
→ traditional Dam/inflammatory supportive role
→ possible immune-modulating potential
↓
Immune–platelet homeostasis
↓
Platelet recovery
However, the immunomodulatory role of Sharbat Unnab specifically in dengue remains a research hypothesis, not an established clinical claim.
🔬 The Bigger Vision
The objective should not be:
“Which Unani medicine increases platelets?”
but:
❗“Which Unani therapeutic axis is disturbed, and can a specific Murakkab restore the biological pathway responsible for platelet recovery?”
This transforms:
Traditional clinical hypothesis → measurable biomarker → controlled clinical study → evidence-generating Applied Unani therapeutics.
Platelet Recovery ≠ Taqwiyat-e-Dam alone.
It may require:
Meda–Ghiza correction + Kabid support + Marrow recovery + Immune/Tilli regulation.
That is the opportunity to develop a genuinely laboratory-integrated, mechanism-oriented Applied Unani approach to thrombocytopenia.
#AppliedUnaniMedicine #UnaniMedicine #Platelets #Thrombocytopenia #Dengue #HabbEPapita #JawarishJalinus #SharbatUnnab #HabbETinkar #IntegrativeMedicine #UnaniResearch
Comments
Post a Comment